LENZ Therapeutics, Inc. Common Stock (LENZ) is a publicly traded Healthcare sector company. As of November 10, 2026, LENZ trades at $4.25 with a market cap of $110.60M and a P/E ratio of -0.87. LENZ moved +22.71% today. Year to date, LENZ is -73.13%; over the trailing twelve months it is -81.28%. Its 52-week range spans $2.80 to $50.40. Analyst consensus is buy with an average price target of $15.80. Rallies surfaces LENZ's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks hedge fund and 13F ownership for LENZ, including fund holders, share counts, and position changes when data is available.
| Metric | Value |
|---|---|
| Price | $4.25 |
| Market Cap | $110.60M |
| P/E Ratio | -0.87 |
| EPS | $-4.13 |
| Dividend Yield | 0.00% |
| 52-Week High | $50.40 |
| 52-Week Low | $2.80 |
| Volume | 1.48M |
| Avg Volume | 0 |
| Revenue (TTM) | $21.48M |
| Net Income | $-126.00M |
| Gross Margin | 0.00% |
6 analysts cover LENZ: 0 strong buy, 4 buy, 2 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $15.80.